Literature DB >> 10602778

Circular antisense oligonucleotides inhibit growth of chronic myeloid leukemia cells.

P T Rowley1, B A Kosciolek, E T Kool.   

Abstract

BACKGROUND: Antisense represents a conceptually powerful method for regulating gene expression. However, antisense oligonucleotides developed to date manifest two serious limitations-nuclease susceptibility and nonspecific hybridization. Circular oligonucleotides may be superior to conventional linear oligonucleotides in both respects. First, circular agents, having no ends, are exonuclease-resistant. Second, they bind to complementary strands of RNA and DNA with a higher affinity than corresponding linear agents. METHODS AND
RESULTS: We assessed the activity of circular phosphodiester deoxynucleotides using chronic myeloid cell lines by targeting polypurine sequences. To represent cells having a bcr3/abl2-type junction, we used K562 cells. A circle targeting a bcr polypurine sequence 385 nucleotides 5' to the junction decreased the cell number by day 5 with an IC(50) of 9 microM. To represent cells having a bcr2/abl2-type junction, we used BV173 cells. A circle targeting the bcr-abl junction itself decreased the cell number by day 7 with an IC(50) of 8 microM. Control oligonucleotides, whether the same sequence uncircularized or circles with the same nucleotide composition but in scrambled sequence, had little effect. Unlike linear agents, circles were stable when incubated in 10% serum. The amount of bcr-abl protein detected by Western blotting using a specific anti-bcr-abl antibody at 24 hr in antisense-treated BV173 cells was only 10% of that of cells treated with control circles, which demonstrates an antisense mechanism of action.
CONCLUSIONS: Circular oligodeoxyribonucleotides (1) inhibit the accumulation of CML cells, (2) decrease the amount of bcr-abl protein per cell, (3) have sequence-selective activity, and (4) are more active than linear oligonucleotides containing only the base-pairing region.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602778      PMCID: PMC2230474     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  22 in total

1.  Relative stabilities of triple helices composed of combinations of DNA, RNA and 2'-O-methyl-RNA backbones: chimeric circular oligonucleotides as probes.

Authors:  S Wang; E T Kool
Journal:  Nucleic Acids Res       Date:  1995-04-11       Impact factor: 16.971

2.  Inhibition of protein-tyrosine kinase activity in intact cells by the aptameric action of oligodeoxynucleotides.

Authors:  R C Bergan; E Kyle; Y Connell; L Neckers
Journal:  Antisense Res Dev       Date:  1995

3.  Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Authors:  J D Rowley
Journal:  Nature       Date:  1973-06-01       Impact factor: 49.962

Review 4.  Antisense oligodeoxynucleotides as therapeutic agents for chronic myelogenous leukemia.

Authors:  G L Nichols
Journal:  Antisense Res Dev       Date:  1995

5.  The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cells.

Authors:  P T Rowley; P C Keng; B A Kosciolek
Journal:  Leuk Res       Date:  1996-06       Impact factor: 3.156

6.  Antisense BCR-ABL oligomers cause non-specific inhibition of chronic myeloid leukemia cell lines.

Authors:  S G O'Brien; M A Kirkland; J V Melo; M H Rao; R J Davidson; C McDonald; J M Goldman
Journal:  Leukemia       Date:  1994-12       Impact factor: 11.528

7.  Unmodified phosphodiester antisense oligodeoxynucleotides to the BCR-ABL junction do not suppress Philadelphia-positive clonogenic cells.

Authors:  A Käbisch; L Pérènyi; U Seay; J Lohmeyer; H Pralle
Journal:  Acta Haematol       Date:  1994       Impact factor: 2.195

8.  Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels.

Authors:  T F Smetsers; L T van de Locht; A H Pennings; H M Wessels; T M de Witte; E J Mensink
Journal:  Leukemia       Date:  1995-01       Impact factor: 11.528

9.  Sequence specificity on the growth suppression and induction of apoptosis of chronic myeloid leukemia cells by BCR-ABL anti-sense oligodeoxynucleoside phosphorothioates.

Authors:  T Maekawa; S Kimura; K Hirakawa; A Murakami; G Zon; T Abe
Journal:  Int J Cancer       Date:  1995-07-04       Impact factor: 7.396

10.  Convergent DNA synthesis: a non-enzymatic dimerization approach to circular oligodeoxynucleotides.

Authors:  E Rubin; S Rumney; S Wang; E T Kool
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

View more
  2 in total

Review 1.  Chemical approaches to control gene expression.

Authors:  J M Gottesfeld; J M Turner; P B Dervan
Journal:  Gene Expr       Date:  2000

2.  Antiproliferative effect in chronic myeloid leukaemia cells by antisense peptide nucleic acids.

Authors:  Valentina Rapozzi; Brigitte E A Burm; Susanna Cogoi; Gijs A van der Marel; Jacques H van Boom; Franco Quadrifoglio; Luigi E Xodo
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.